BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 25860928)

  • 1. Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway.
    Tabouret E; Tchoghandjian A; Denicolai E; Delfino C; Metellus P; Graillon T; Boucard C; Nanni I; Padovani L; Ouafik L; Figarella-Branger D; Chinot O
    Oncotarget; 2015 May; 6(13):11664-75. PubMed ID: 25860928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in PlGF and MET-HGF expressions in paired initial and recurrent glioblastoma.
    Tabouret E; Denicolai E; Delfino C; Graillon T; Boucard C; Nanni I; Padovani L; Figarella-Branger D; Chinot O
    J Neurooncol; 2016 Dec; 130(3):431-437. PubMed ID: 27566180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioblastoma: patterns of recurrence and efficacy of salvage treatments.
    Oh J; Sahgal A; Sanghera P; Tsao MN; Davey P; Lam K; Symons S; Aviv R; Perry JR
    Can J Neurol Sci; 2011 Jul; 38(4):621-5. PubMed ID: 21672702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of angiogenesis related factors in glioblastoma, peritumoral tissue and their derived cancer stem cells.
    D'Alessio A; Proietti G; Lama G; Biamonte F; Lauriola L; Moscato U; Vescovi A; Mangiola A; Angelucci C; Sica G
    Oncotarget; 2016 Nov; 7(48):78541-78556. PubMed ID: 27705944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoirradiation for glioblastoma multiforme: the national cancer institute experience.
    Ho J; Ondos J; Ning H; Smith S; Kreisl T; Iwamoto F; Sul J; Kim L; McNeil K; Krauze A; Shankavaram U; Fine HA; Camphausen K
    PLoS One; 2013; 8(8):e70745. PubMed ID: 23940635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.
    Kioi M; Vogel H; Schultz G; Hoffman RM; Harsh GR; Brown JM
    J Clin Invest; 2010 Mar; 120(3):694-705. PubMed ID: 20179352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditional probability of survival and post-progression survival in patients with glioblastoma in the temozolomide treatment era.
    McNamara MG; Lwin Z; Jiang H; Chung C; Millar BA; Sahgal A; Laperriere N; Mason WP
    J Neurooncol; 2014 Mar; 117(1):153-60. PubMed ID: 24469855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.
    Navone SE; Guarnaccia L; Cordiglieri C; Crisà FM; Caroli M; Locatelli M; Schisano L; Rampini P; Miozzo M; La Verde N; Riboni L; Campanella R; Marfia G
    World Neurosurg; 2018 Dec; 120():e380-e391. PubMed ID: 30144594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioblastoma management in the temozolomide era: have we improved outcome?
    Lwin Z; MacFadden D; Al-Zahrani A; Atenafu E; Miller BA; Sahgal A; Menard C; Laperriere N; Mason WP
    J Neurooncol; 2013 Nov; 115(2):303-10. PubMed ID: 23979682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CXCL12/CXCR4 axis confers temozolomide resistance to human glioblastoma cells via up-regulation of FOXM1.
    Wang S; Chen C; Li J; Xu X; Chen W; Li F
    J Neurol Sci; 2020 Jul; 414():116837. PubMed ID: 32334273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial.
    Malmström A; Poulsen HS; Grønberg BH; Stragliotto G; Hansen S; Asklund T; Holmlund B; Łysiak M; Dowsett J; Kristensen BW; Söderkvist P; Rosell J; Henriksson R;
    Acta Oncol; 2017 Dec; 56(12):1776-1785. PubMed ID: 28675067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR7 and CXCR4 Expressions in Infiltrative Astrocytomas and Their Interactions with HIF1α Expression and IDH1 Mutation.
    Bianco AM; Uno M; Oba-Shinjo SM; Clara CA; de Almeida Galatro TF; Rosemberg S; Teixeira MJ; Nagahashi Marie SK
    Pathol Oncol Res; 2015 Apr; 21(2):229-40. PubMed ID: 24970694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of O6-methylguanine-DNA methyltransferase (MGMT) protein expression as prognostic marker in glioblastoma patients treated with radiation therapy with concomitant and adjuvant Temozolomide.
    Younis SG; Khedr RA; El-Shorbagy SH
    J Egypt Natl Canc Inst; 2016 Mar; 28(1):23-30. PubMed ID: 26682634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL12 and CXCR4 as predictive biomarkers of glioma recurrence pattern after total resection.
    Tang W; Wang X; Chen Y; Zhang J; Chen Y; Lin Z
    Pathol Biol (Paris); 2015 Sep; 63(4-5):190-8. PubMed ID: 26277915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review.
    Ashby LS; Smith KA; Stea B
    World J Surg Oncol; 2016 Aug; 14(1):225. PubMed ID: 27557526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CXCL12 on pseudopalisading cells and proliferating microvessels in glioblastomas: an accelerated growth factor in glioblastomas.
    Komatani H; Sugita Y; Arakawa F; Ohshima K; Shigemori M
    Int J Oncol; 2009 Mar; 34(3):665-72. PubMed ID: 19212671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of salvage treatment for recurrent glioblastoma.
    Kim HR; Kim KH; Kong DS; Seol HJ; Nam DH; Lim DH; Lee JI
    J Clin Neurosci; 2015 Mar; 22(3):468-73. PubMed ID: 25595963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution.
    Michaelsen SR; Christensen IJ; Grunnet K; Stockhausen MT; Broholm H; Kosteljanetz M; Poulsen HS
    BMC Cancer; 2013 Sep; 13():402. PubMed ID: 24004722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time trends in glioblastoma multiforme survival: the role of temozolomide.
    Dubrow R; Darefsky AS; Jacobs DI; Park LS; Rose MG; Laurans MS; King JT
    Neuro Oncol; 2013 Dec; 15(12):1750-61. PubMed ID: 24046259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard (60 Gy) or short-course (40 Gy) irradiation plus concomitant and adjuvant temozolomide for elderly patients with glioblastoma: a propensity-matched analysis.
    Minniti G; Scaringi C; Lanzetta G; Terrenato I; Esposito V; Arcella A; Pace A; Giangaspero F; Bozzao A; Enrici RM
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):109-15. PubMed ID: 25442339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.